PepsiCo has appointed Joaquin Duato, Chairman and CEO of Johnson & Johnson, to its Board of Directors. Duato currently leads Johnson & Johnson, a major global healthcare group with a large portfolio of consumer and pharmaceutical brands. His appointment adds senior healthcare and international experience to PepsiCo's board as the business focuses on health oriented product lines. Duato's experience with complex, global operations is also relevant to PepsiCo's heavy investment in AI, ERP and supply chain integration, where execution risk has been flagged. The clearest early signal to watch is how PepsiCo's board and management talk about health oriented innovation and North America productivity in 2027 guidance and in earnings calls following Duato's December 1, 2026 start.
PepsiCo IncPepsiCo appoints J&J CEO Joaquin Duato to its board, adding healthcare and global-operations expertise as it focuses on health-oriented products and AI/ERP/supply-chain execution.
Johnson & Johnson